Erythema: Types, Causes, and Treatment

You've been told your skin is sensitive. You've tried every cream. But when redness shows up and won't leave, the problem isn't always at the surface. Erythema, the medical term for skin redness caused by increased blood flow, is often a visible signal of something happening deeper in your body. It's not just about irritation or a bad product. It's your immune system responding to an infection, a medication, or an internal trigger you haven't identified yet.

Key Takeaways

• Erythema is redness caused by dilated blood vessels, not surface-level irritation.
• Erythema multiforme is an immune reaction, most often triggered by herpes simplex virus.
• Erythema nodosum is a form of panniculitis affecting subcutaneous fat, not just skin.
• Both conditions can signal systemic infections, autoimmune activity, or medication reactions.
• Persistent or recurrent erythema warrants investigation beyond topical treatments.
• Biomarkers like hsCRP and immune markers can reveal underlying inflammatory drivers.

What Erythema Actually Is and Where It Starts

Erythema is redness of the skin caused by increased blood flow to capillaries near the surface. It's not a diagnosis. It's a description of what your skin is doing in response to something else. That something could be an infection, an immune reaction, a medication, or an inflammatory process happening elsewhere in your body. The redness blanches when you press on it, meaning it temporarily disappears under pressure as blood is pushed out of the capillaries. This distinguishes it from purpura or petechiae, where blood has leaked out of vessels and won't blanch.

Erythema can be localized or widespread. It can appear suddenly or develop gradually. The pattern, distribution, and associated symptoms help determine what's driving it. Two of the most clinically significant forms are erythema multiforme and erythema nodosum. Both are immune-mediated and can be triggered by infections or medications. They're often misunderstood as purely dermatologic conditions when they're actually systemic signals.

Erythema Multiforme: An Immune Reaction That Starts With a Virus

Erythema multiforme is an acute hypersensitivity reaction that produces distinctive target-like lesions on the skin. These lesions have a central dark spot surrounded by a pale ring and an outer red ring, resembling a bullseye. The erythema multiforme rash typically appears on the hands, feet, and face, and can involve mucous membranes. In most cases, it's triggered by herpes simplex virus, particularly HSV-1. The virus doesn't need to be actively causing a cold sore. Viral DNA fragments can persist in skin cells and trigger an immune response weeks after the initial infection.

The mechanism involves CD8+ T cells recognizing viral antigens in the skin and mounting an inflammatory response. This isn't a direct viral infection of the skin. It's an immune overreaction to viral remnants. Other triggers include:

• Mycoplasma pneumoniae, which causes atypical pneumonia and often precedes the rash by one to two weeks.
• Medications like sulfonamides and anticonvulsants, which typically trigger reactions one to three weeks after initiation.
• Vaccines, though this is less common than infectious or medication-related triggers.

In some cases, no trigger is identified. The condition is self-limiting in most people, resolving within two to four weeks. However, recurrent erythema multiforme (defined as four or more episodes per year) is almost always associated with recurrent herpes simplex virus reactivation.

How Erythema Multiforme Connects to Immune Function and Viral Load

Erythema multiforme is not just a skin reaction. It's a window into how your immune system handles latent viral infections. Herpes simplex virus establishes lifelong latency in nerve cells. Periodic reactivation is normal. But in some individuals, the immune response to reactivation is exaggerated, producing the characteristic skin lesions of erythema multiforme. This suggests an imbalance in immune regulation, where the response to viral antigens is disproportionate to the actual viral threat.

Research has shown that individuals with recurrent erythema multiforme have altered T-cell responses to HSV antigens. Their immune systems are primed to overreact. This can be influenced by stress (which elevates cortisol and suppresses certain immune pathways) or by other infections that shift immune balance. The condition is more common in young adults, and there's some evidence that genetic factors influence susceptibility. If you have recurrent episodes, it's worth investigating not just the trigger but the underlying immune tone that makes you prone to these reactions.

What Drives Flares and Severity in Erythema Multiforme

The primary driver of erythema multiforme is viral reactivation, particularly herpes simplex virus. Anything that triggers HSV reactivation can precipitate an episode:

• UV exposure, which can reactivate latent virus in skin cells.
• Fever, which creates an environment conducive to viral replication.
• Stress, which suppresses immune surveillance of latent infections.
• Menstruation, likely due to hormonal fluctuations affecting immune function.
• Immune suppression from illness or medications.

Medications are the second most common trigger. Sulfonamide antibiotics, NSAIDs, anticonvulsants, and allopurinol are frequently implicated. The reaction typically occurs one to three weeks after starting the medication, though it can happen sooner with re-exposure. Mycoplasma pneumoniae is another well-documented trigger, particularly in children and young adults. Other infections (including Epstein-Barr virus, cytomegalovirus, and certain fungal infections) have been reported as triggers. In some cases, the condition appears to be idiopathic, meaning no clear trigger is identified despite thorough investigation.

Why the Same Condition Looks Different in Different People

Erythema multiforme exists on a spectrum. Erythema multiforme minor involves skin lesions with minimal or no mucosal involvement. Erythema multiforme major involves extensive mucosal erosions, particularly of the mouth and eyes, and can be debilitating. The distinction is clinical, not pathologic. The same immune mechanism is at play. What differs is the intensity and distribution of the response.

Individual variation in immune response explains much of this. Some people mount a localized reaction to viral antigens. Others develop a more widespread inflammatory response. Genetic factors (including HLA type) influence susceptibility. Prior exposure to the trigger also matters. First episodes tend to be more severe than recurrent episodes, suggesting some degree of immune adaptation. Age, sex, and baseline immune function all play a role. Women are more likely to develop recurrent erythema multiforme, possibly due to hormonal influences on immune regulation.

When Skin Symptoms Point to Something Systemic

Erythema multiforme is usually a self-limited condition. But when it's recurrent, severe, or associated with systemic symptoms, it warrants deeper investigation. Recurrent episodes suggest an underlying trigger that hasn't been addressed. If herpes simplex virus is the culprit, antiviral prophylaxis with acyclovir or valacyclovir can prevent recurrences. If a medication is suspected, discontinuation is essential.

Severe mucosal involvement, particularly of the eyes, can lead to complications including scarring and vision loss. This requires aggressive management and ophthalmologic consultation. Systemic symptoms like fever, malaise, or joint pain suggest a more widespread inflammatory process. In these cases, testing for underlying infections, autoimmune markers, and inflammatory biomarkers is appropriate. Erythema multiforme can occasionally overlap with Stevens-Johnson syndrome, a more severe mucocutaneous reaction that requires hospitalization.

Erythema Nodosum: Inflammation of the Fat Layer Beneath the Skin

What erythema nodosum looks like and who it affects

Erythema nodosum is a form of panniculitis, an inflammatory condition affecting the subcutaneous fat. It presents as tender, erythematous nodules, typically on the shins. The nodules are raised, warm to the touch, and painful. They don't ulcerate or drain. Over weeks, they evolve from red to purple to yellow-brown, resembling a bruise. The condition is more common in women and typically occurs in young to middle-aged adults.

Common triggers and underlying associations

Erythema nodosum is a hypersensitivity reaction to an underlying trigger. The most common triggers are streptococcal infections, sarcoidosis, inflammatory bowel disease, tuberculosis, and certain medications (including oral contraceptives and antibiotics). In many cases, no specific trigger is identified. The condition is self-limiting, usually resolving within six weeks. However, it can recur, and recurrent cases warrant investigation for chronic infections, autoimmune conditions, or malignancy.

How Erythema Nodosum Connects to Immune and Inflammatory Pathways

Erythema nodosum is not a primary disease of the skin. It's a reaction pattern triggered by systemic inflammation. The nodules form when immune cells infiltrate the fat layer beneath the skin, releasing inflammatory mediators that cause swelling, pain, and redness. This is a septal panniculitis, meaning the inflammation primarily affects the connective tissue septa that divide fat lobules, rather than the fat cells themselves.

The condition is strongly associated with sarcoidosis, a systemic granulomatous disease that affects multiple organs. In fact, erythema nodosum is one of the hallmark features of Lofgren syndrome (a form of acute sarcoidosis characterized by bilateral hilar lymphadenopathy, arthritis, and erythema nodosum). Inflammatory bowel disease, particularly Crohn's disease, is another common association. The nodules often appear during disease flares, suggesting a shared inflammatory pathway. Streptococcal pharyngitis is a frequent trigger in children and young adults, typically appearing two to three weeks after the infection.

What Drives Flares and Severity in Erythema Nodosum

The primary drivers of erythema nodosum are infections, medications, and systemic inflammatory conditions:

• Streptococcal infections are the most common infectious trigger, particularly in children and young adults.
• Tuberculosis, particularly in endemic areas, is another important cause requiring screening.
• Yersinia, Salmonella, and Campylobacter infections have all been reported as triggers.
• Oral contraceptives, sulfonamides, and penicillins are frequently implicated medications.
• Sarcoidosis and inflammatory bowel disease are the most common systemic associations.

The reaction typically occurs within weeks of starting a medication. In sarcoidosis and inflammatory bowel disease cases, erythema nodosum is not a complication. It's a manifestation of the underlying disease. Other associations include Behcet's disease, lupus, and malignancies (particularly lymphoma). Pregnancy is a known trigger, likely due to hormonal and immune changes. In up to 50% of cases, no specific trigger is identified despite thorough investigation. These idiopathic cases tend to resolve spontaneously and have a good prognosis.

Why Responses Vary in Erythema Nodosum

Erythema nodosum is more common in women, with a female-to-male ratio of approximately 3:1. This suggests hormonal influences on immune response. Estrogen modulates immune function, and fluctuations in estrogen levels (such as those occurring with oral contraceptive use or pregnancy) can trigger episodes. Genetic factors also play a role. Certain HLA types are associated with increased susceptibility, particularly in sarcoidosis-related cases.

The severity and duration vary widely. Some individuals develop a few nodules that resolve within weeks. Others develop extensive, painful lesions that persist for months. The difference often relates to the underlying trigger. Infection-related cases tend to resolve once the infection is treated. Sarcoidosis-related cases may persist or recur, reflecting ongoing systemic inflammation. Idiopathic cases generally have the best prognosis, with most resolving within six weeks and not recurring.

When Skin Symptoms Signal Systemic Disease

Erythema nodosum is a clinical diagnosis, but it's not a standalone condition. It's a signal that something else is happening in your body. If you develop erythema nodosum, the first step is to identify the trigger. This involves a thorough history (including recent infections, medications, and systemic symptoms). A chest X-ray is often performed to screen for sarcoidosis and tuberculosis. Blood tests (including ESR, hsCRP, and antistreptolysin O titers) can help identify infection or inflammation.

If sarcoidosis is suspected, further testing may include serum angiotensin-converting enzyme levels and pulmonary function tests. If inflammatory bowel disease is suspected, colonoscopy and imaging may be warranted. Recurrent erythema nodosum (particularly in the absence of an obvious trigger) should prompt investigation for chronic infections, autoimmune conditions, and malignancy. The condition itself is benign, but the underlying cause may not be.

What Biomarkers Can Tell You When Topicals Aren't Enough

When erythema is persistent, recurrent, or associated with systemic symptoms, biomarkers can help identify the underlying driver:

• Inflammatory markers like hsCRP and ESR are elevated in conditions like erythema nodosum and can track disease activity.
• Immune markers (including ANA and rheumatoid factor) can screen for autoimmune conditions.
• Infectious workup (including streptococcal titers, tuberculosis testing, and viral serologies) can identify triggers.
• Thyroid function, Vitamin D, and ferritin testing can reveal deficiencies that influence immune function.

For recurrent erythema multiforme, consider testing for chronic herpes simplex virus infection. For erythema nodosum treatments to be effective, chest imaging and inflammatory markers are essential. Tracking these markers over time (not just reacting to individual flares) is more likely to identify the underlying driver.

Getting to the Root of What's Driving Your Skin

If your skin keeps reacting and you've ruled out the obvious triggers, Superpower's 100+ biomarker panel can show you what's happening at the immune and inflammatory level. Persistent erythema isn't just a skin problem. It's a signal that your body is responding to something deeper. Superpower's panel measures inflammatory markers, immune function, nutrient status, and metabolic health, giving you a clearer picture of what's driving your symptoms so your next step is based on data, not guesswork.